242 results
Page 5 of 13
8-K
EX-99.1
ppk5ffg2
13 Sep 21
MIMEDX Reports Top-line Data from Two Late-Stage Musculoskeletal Trials with Proprietary Amniotic Tissue Technology
6:33am
8-K
EX-99.2
xgra 17k2r2ude
13 Sep 21
MIMEDX Reports Top-line Data from Two Late-Stage Musculoskeletal Trials with Proprietary Amniotic Tissue Technology
6:33am
8-K
ooaom3
13 Sep 21
MIMEDX Reports Top-line Data from Two Late-Stage Musculoskeletal Trials with Proprietary Amniotic Tissue Technology
6:33am
8-K
jmwgtnzfetoew
3 Aug 21
MIMEDX Announces Second Quarter 2021
5:26pm
8-K
EX-99.1
zwpgv
3 Aug 21
MIMEDX Announces Second Quarter 2021
5:26pm
8-K
tl86tz7fv bc
23 Jun 21
Results of Operations and Financial Condition
8:33am
8-K
EX-99.1
ulb0nh1ij2qr h9s5
12 May 21
Regulation FD Disclosure
8:20am
8-K
jka4yru8jm
12 May 21
Regulation FD Disclosure
8:20am
DEFA14A
28poq
7 May 21
Additional proxy soliciting materials
10:56am
DEFC14A
edoknllo3j1
3 May 21
Proxy in contested solicitation
9:36am
DEFA14A
9g62j
3 May 21
Additional proxy soliciting materials
8:28am
8-K
EX-99.1
msfrb1ux3wl7qqi0
3 May 21
Regulation FD Disclosure
8:00am
DEFA14A
f71nm
30 Apr 21
Additional proxy soliciting materials
5:10pm
DEFC14A
rcsdb2yv
30 Apr 21
Proxy in contested solicitation
5:02pm
DEFA14A
exkg2o354ekuiz1
28 Apr 21
Additional proxy soliciting materials
5:13pm
8-K
EX-99.1
gexq5
28 Apr 21
MiMedx Announces First Quarter 2021 Financial and Operating Results
5:09pm